Sterling Pharma Solutions
Sterling Pharma Solutions is a provider of development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) tailored to the pharmaceutical industry. The company specializes in outsourced contract manufacturing, offering expertise in API development, medical engineering, project management, and supply chain management. By delivering contract good manufacturing practices (GMP) services, Sterling Pharma Solutions enables its clients to concentrate on their projects throughout the entire product lifecycle, ensuring high-quality support and efficiency in their operations.
Top Sectors
Top Stages
1 past transactions
ADC Biotechnology
Acquisition in 2021
ADC Biotechnology Ltd is a UK-based company specializing in the development of antibody-drug conjugates (ADCs) for cancer treatment. Founded in 2010 and formerly known as Reaxa Biotech Ltd, the company has created a patented Lock-Release technology that streamlines the drug purification process by reducing the number of steps and associated risks. This innovative approach not only simplifies the development of ADCs but also lowers costs for drug developers. In addition to its proprietary technology, ADC Biotechnology offers a range of consultancy and research and development services to support the testing and production of new ADC-based therapies aimed at specifically targeting and destroying tumor cells.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.